---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-011367"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2022-02-03T23:59:59+00:00"
generated_at: "2026-06-27T11:41:34.688159+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "medium"
source: SEC EDGAR
---

# Biostage posts webinar video; interim CEO outlines plans for clinical trial, capital raise, NASDAQ uplisting

## Summary
- Biostage posted video of January 27 webinars with founder/interim CEO David Green.
- Webinar covered plans for approved clinical trial, raising capital, and uplisting to NASDAQ.
- Video includes Q&A sessions from both webinars.

## SEC filing metadata
- accession: 0001104659-22-011367
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2022-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000110465922011367/0001104659-22-011367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000110465922011367/tm225487d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-011367
- JSON: https://secwatch.observer/filing/0001104659-22-011367.json
- Plain text: https://secwatch.observer/filing/0001104659-22-011367.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.